# FDA Inspection 1141819 - Antonio E. Terrelonge - April 28, 2021

Source: https://www.keypedia.com/records/fda_inspections/antonio-e-terrelonge/58c58242-8535-48c4-86c7-8e5d09b8b7b6
Source feed: FDA_Inspections

> FDA Inspection 1141819 for Antonio E. Terrelonge on April 28, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141819
- Company Name: Antonio E. Terrelonge
- Inspection Date: 2021-04-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1098288 - 2019-07-29](https://www.keypedia.com/records/fda_inspections/antonio-e-terrelonge/d367d32d-23e8-47b5-a9c4-54d5e531e881)
- [FDA Inspection 1020097 - 2017-07-20](https://www.keypedia.com/records/fda_inspections/antonio-e-terrelonge/08b7d6e9-5d11-4835-ba0d-eb041bf16e23)

Company: https://www.keypedia.com/companies/antonio-e-terrelonge/c0f36985-9a2a-428a-b360-3ebbba308cc0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c